Facebook (FB) Valuation Declined While Miura Global Management Trimmed Holding by $13.20 Million; As Sarepta Therapeutics (Call) (SRPT) Stock Price Rose, D-E Shaw & Company Lifted Its Position

April 20, 2018 - By wolcottdaily

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Logo

David Shaw increased its stake in Sarepta Therapeutics Inc (Call) (SRPT) by 21.51% based on its latest 2017Q4 regulatory filing with the SEC. D-E Shaw & Company Inc bought 10,000 shares as the company’s stock rose 36.45% while stock markets declined. The hedge fund run by David Shaw held 56,500 shares of the health care company at the end of 2017Q4, valued at $3.14M, up from 46,500 at the end of the previous reported quarter. D-E Shaw & Company Inc who had been investing in Sarepta Therapeutics Inc (Call) for a number of months, seems to be bullish on the $5.20 billion market cap company. The stock increased 1.78% or $1.4 during the last trading session, reaching $79.95. About 660,873 shares traded. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) has risen 149.90% since April 20, 2017 and is uptrending. It has outperformed by 138.35% the S&P500.

Pasco Alfaro / Richard Tumure decreased its stake in Facebook Inc (FB) by 37.5% based on its latest 2017Q4 regulatory filing with the SEC. Miura Global Management Llc sold 75,000 shares as the company’s stock declined 14.10% with the market. The hedge fund run by Pasco Alfaro / Richard Tumure held 125,000 shares of the technology company at the end of 2017Q4, valued at $22.06M, down from 200,000 at the end of the previous reported quarter. Miura Global Management Llc who had been investing in Facebook Inc for a number of months, seems to be less bullish one the $485.16B market cap company. The stock decreased 0.46% or $0.765 during the last trading session, reaching $167.335. About 12.49 million shares traded. Facebook, Inc. (NASDAQ:FB) has risen 8.48% since April 20, 2017 and is uptrending. It has underperformed by 3.07% the S&P500.

Investors sentiment increased to 1.21 in 2017 Q4. Its up 0.06, from 1.15 in 2017Q3. It increased, as 57 investors sold FB shares while 621 reduced holdings. 147 funds opened positions while 670 raised stakes. 1.61 billion shares or 1.26% less from 1.63 billion shares in 2017Q3 were reported. Jarislowsky Fraser accumulated 1,750 shares. Zevin Asset Management Limited Liability Corp reported 4,158 shares. Wesbanco Financial Bank Inc reported 47,792 shares. Ancora Lc has 15,878 shares for 0.15% of their portfolio. Glg reported 113,245 shares stake. Shamrock Asset Limited Company owns 0.02% invested in Facebook, Inc. (NASDAQ:FB) for 166 shares. Zweig reported 3.04% stake. Btim Corp reported 0.02% in Facebook, Inc. (NASDAQ:FB). Wall Street Access Asset Management Ltd Liability Corporation stated it has 4,335 shares or 1.21% of all its holdings. Select Equity Grp Limited Partnership invested in 0.07% or 47,430 shares. Weiss Multi accumulated 150,000 shares. Mark Sheptoff Finance Planning Ltd accumulated 1,356 shares or 0.16% of the stock. Ubs Oconnor Ltd Liability Corporation has invested 0.18% in Facebook, Inc. (NASDAQ:FB). Blue Financial Cap, Rhode Island-based fund reported 27,659 shares. Mufg Americas has 2.7% invested in Facebook, Inc. (NASDAQ:FB).

Among 55 analysts covering Facebook (NASDAQ:FB), 50 have Buy rating, 2 Sell and 3 Hold. Therefore 91% are positive. Facebook had 253 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Facebook, Inc. (NASDAQ:FB) earned “Buy” rating by Stifel Nicolaus on Thursday, November 5. As per Thursday, March 22, the company rating was maintained by Stifel Nicolaus. Bank of America maintained it with “Buy” rating and $18000 target in Monday, July 24 report. The stock of Facebook, Inc. (NASDAQ:FB) earned “Buy” rating by Bank of America on Thursday, November 5. Morgan Stanley maintained Facebook, Inc. (NASDAQ:FB) rating on Thursday, February 1. Morgan Stanley has “Overweight” rating and $230 target. Canaccord Genuity maintained Facebook, Inc. (NASDAQ:FB) on Thursday, June 15 with “Buy” rating. The stock of Facebook, Inc. (NASDAQ:FB) has “Buy” rating given on Thursday, April 28 by UBS. The rating was maintained by RBC Capital Markets with “Outperform” on Thursday, January 28. The rating was maintained by William Blair with “Buy” on Thursday, July 20. Moffett Nathanson initiated it with “Buy” rating and $105 target in Tuesday, September 8 report.

Since October 17, 2017, it had 0 buys, and 41 sales for $1.29 billion activity. Zuckerberg Mark had sold 145,000 shares worth $22.98M on Thursday, March 29. 55,000 shares were sold by Sandberg Sheryl, worth $10.07 million. 4,699 Facebook, Inc. (NASDAQ:FB) shares with value of $806,019 were sold by FISCHER DAVID B.. Wehner David M. also sold $2.66M worth of Facebook, Inc. (NASDAQ:FB) shares. $6.64 million worth of Facebook, Inc. (NASDAQ:FB) was sold by Schroepfer Michael Todd on Tuesday, February 13. Another trade for 1.25 million shares valued at $221.33M was sold by Koum Jan.

Analysts await Facebook, Inc. (NASDAQ:FB) to report earnings on April, 25 after the close. They expect $1.36 earnings per share, up 30.77% or $0.32 from last year’s $1.04 per share. FB’s profit will be $3.94B for 30.76 P/E if the $1.36 EPS becomes a reality. After $2.20 actual earnings per share reported by Facebook, Inc. for the previous quarter, Wall Street now forecasts -38.18% negative EPS growth.

Miura Global Management Llc, which manages about $2.90B and $344.33M US Long portfolio, upped its stake in Visa Inc (NYSE:V) by 120,000 shares to 500,000 shares, valued at $57.01 million in 2017Q4, according to the filing.

Investors sentiment decreased to 1.22 in 2017 Q4. Its down 1.66, from 2.88 in 2017Q3. It fall, as 27 investors sold SRPT shares while 67 reduced holdings. 45 funds opened positions while 70 raised stakes. 52.88 million shares or 2.28% more from 51.70 million shares in 2017Q3 were reported. Art Advsrs Ltd Com reported 29,900 shares. Atlantic Tru Limited Liability Com has invested 0% in Sarepta Therapeutics, Inc. (NASDAQ:SRPT). Royal Comml Bank Of Canada holds 0.01% or 295,322 shares in its portfolio. Alliancebernstein Lp holds 0% of its portfolio in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) for 117,340 shares. Hikari has 25,000 shares for 0.16% of their portfolio. Citadel Advsrs Ltd Com, a Illinois-based fund reported 449,702 shares. Tiaa Cref Investment Limited Liability Company holds 0.01% of its portfolio in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) for 193,096 shares. Cubist Systematic Strategies Ltd Liability holds 0% in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) or 973 shares. Raymond James Finance Advsr Inc invested 0.01% in Sarepta Therapeutics, Inc. (NASDAQ:SRPT). Eagle Asset Management, Florida-based fund reported 986,783 shares. 5,161 are held by Ameritas. Weiss Multi reported 110,000 shares or 0.16% of all its holdings. 5,483 are held by Advisory Svcs Ntwk Lc. New York-based Tocqueville Asset Limited Partnership has invested 0.02% in Sarepta Therapeutics, Inc. (NASDAQ:SRPT). Camber Ltd stated it has 0.82% in Sarepta Therapeutics, Inc. (NASDAQ:SRPT).

Among 27 analysts covering Sarepta Therapeutics (NASDAQ:SRPT), 21 have Buy rating, 0 Sell and 6 Hold. Therefore 78% are positive. Sarepta Therapeutics had 113 analyst reports since August 5, 2015 according to SRatingsIntel. The firm earned “Neutral” rating on Friday, August 7 by Suntrust Robinson. The firm earned “Outperform” rating on Tuesday, October 18 by Credit Suisse. As per Wednesday, February 21, the company rating was maintained by J.P. Morgan. The firm has “Buy” rating given on Wednesday, June 28 by Credit Suisse. The stock of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) earned “Buy” rating by Vetr on Tuesday, August 25. The company was maintained on Wednesday, March 7 by SunTrust. The rating was maintained by Leerink Swann with “Outperform” on Tuesday, March 13. The firm has “Buy” rating by H.C. Wainwright given on Monday, March 12. The firm has “Buy” rating given on Friday, July 21 by William Blair. Bank of America reinitiated the stock with “Buy” rating in Friday, October 23 report.

D-E Shaw & Company Inc, which manages about $81.36 billion and $72.62 billion US Long portfolio, decreased its stake in Altisource Residential Corp (NYSE:RESI) by 35,374 shares to 363,188 shares, valued at $4.31 million in 2017Q4, according to the filing. It also reduced its holding in Graphic Packaging Hldg Co (NYSE:GPK) by 734,799 shares in the quarter, leaving it with 5.16M shares, and cut its stake in Myr Group Inc Del (NASDAQ:MYRG).

Facebook, Inc. (NASDAQ:FB) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

>